Not long after last month’s Healthkit post, Jawbone updated their Blue app so it would connect directly with HealhtKit. So instead of data being transmitted from Blue Jawbone to Purple Jawbone to HealthKit, it now goes from Blue Jawbone to HealthKit directly. They did it quietly, with any communication to band owners. One day the [...]
Pharma
Apple HealthKit First Impressions
October 15, 2014 0 commentsFor the health geeks, one of the subtle announcements of the big Apple keynote last month was HealthKit. HealthKit allows apps that provide health and fitness services to share their data with the new Health app and with each other. In a rare false start for Apple, HealthKit didn’t make the iOS 8 release, but [...]
Could There be Luck in the Twitter Cards for Pharma?
May 23, 2014 0 commentsToday’s PM360 Panorama featured an article “Fifteen Ways Pharma Can Take Advantage of Twitter’s Redesign.” My comments were featured in the article, and the full article is here. Below are some further thoughts on the redesign and its applicability for pharma. With a full header image and stats on friends and photos, I can hardly [...]
FDA’s Draft Guidance on Interactive Promotional Media – First Week Responses
January 17, 2014 0 commentsEarly Monday morning, the FDA released guidance for review on Interactive Promotional Media. This was the first tangible guidance since the FDA hearings on Pharma Social Media in November 2009, and for some this was a real occasion to open the champagne. Bill Evans at the industry leading Dose of Digital was the first to [...]
Facebook Timequake Coming for Pharma 3/30!
March 22, 2012 4 commentsIf you have any doubts on who is in charge of calling the shots on Social Media, stop wondering. It’s Facebook, by size and impact. The platform is in control and the timelines to adapt to change are shortening. Facebook rolled out Timeline to brands on 2/29 and all brand pages will be forced to [...]
End of the Year Surprise: FDA Draft Guidance for Off-Label Information
January 5, 2012 0 commentsOver the holidays, and without fanfare, the FDA issued Draft Guidance for Responding to Unsolicited Requests for Off-Label Information. The title of the guidance is a little deceptive in that within the document lies some draft guidance on dealing with social media in the form of ‘public’ platforms where some of this conversation may take [...]